Minodronate for glucocorticoid induced osteoporosis versus alfacalcidol
Phase of Trial: Phase IV
Latest Information Update: 05 Mar 2019
Price : $35 *
At a glance
- Drugs Minodronic acid (Primary) ; Alfacalcidol
- Indications Corticosteroid-induced osteoporosis
- Focus Therapeutic Use
- Acronyms m-GLORIA
- 19 Oct 2018 Status has been changed to completed.
- 05 Sep 2018 Status changed from active, no longer recruiting to discontinued.
- 20 Jun 2016 Status changed from recruiting to active, no longer recruiting.